Diabetes

NEW YORK — Mothers that have low socioeconomic status and develop gestational diabetes during pregnancy are more likely to bear children that are diagnosed with attention deficit hyperactivity disorder, according to a new study published in the Archives of Pediatrics & Adolescent Medicine.

CHICAGO — A group of dietitians with the Academy of Nutrition and Dietetics has conducted a review of smartphone applications for weight management, diabetes and gluten-free eating, the organization said.

The AND — formerly the American Dietetic Association — said the purpose of the review, which includes 30 of the most popular, free iPhone apps, was to help consumers sift through the numerous apps available.

DEERFIELD, Ill. — Medication adherence is as high or slightly better among patients filling 90-day prescriptions at retail versus mail order, according to a new Walgreens study published in the November issue of the American Journal of Managed Care that the chain highlighted Thursday.

According to the study, adherence levels for 90-day at retail were 77%, while at mail-order adherence levels were 76%.

WASHINGTON — Larry Hausner, the CEO of the American Diabetes Association, will serve as the 2012 chairman of the National Health Council's board of directors, NHC said.

WORCESTER, Mass. — An interdisciplinary research team at Worcester Polytechnic Institute is slated to develop a smartphone application that will help patients with advanced diabetes and foot ulcers.

WORCESTER, Mass. — Researchers at the University of Massachusetts Medical School said a diabetes prevention program they created was able to reduce prediabetes indicators among Latinos who were at risk of developing the disease.

NEW YORK — Israeli drug maker Teva Pharmaceutical Industries is developing a protein that could offer a new way to treat Type 1 diabetes, according to published reports.

Type 1 diabetes is an autoimmune disorder in which the immune system attacks the pancreas's beta cells, but the drug, DiaPep277, stops that from happening, according to Bloomberg.

NEW YORK — What new prescription and OTC drugs are top of mind among retail pharmacists? How often do pharmacists REALLY recommend private label?